Carregant...
Real-world experience with pembrolizumab in patients with advanced melanoma: A large retrospective observational study
Pembrolizumab has been approved in the United States for treating advanced melanoma for >4 years. We examined real-world pembrolizumab use and associated outcomes in US oncology clinical practices, including patients who would not be eligible for clinical trials. Flatiron Health longitudinal data...
Guardat en:
| Publicat a: | Medicine (Baltimore) |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Health
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709121/ https://ncbi.nlm.nih.gov/pubmed/31348273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016542 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|